OFG
GTHX

Oxford Financial Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Oxford Financial Group’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,416
Closed -$421K – 235
2020
Q4 		$421K Hold
23,416
– – 0.06% 120
2020
Q3 		$270K Hold
23,416
– – 0.04% 136
2020
Q2 		$568K Hold
23,416
– – 0.1% 87
2020
Q1 		$258K Buy
+23,416
New +$437K 0.05% 132

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Oxford Financial Group's GTHX Position: Q1 2021 in Review

Oxford Financial Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2021, closing a stake of 23,416 shares — an estimated $421K sold.

Oxford Financial Group first reported a position in GTHX in Q1 2020 and held it in 4 quarters. The position peaked at $568K in Q2 2020. 123 funds tracked by Wall St. Rank hold GTHX as of Q1 2021.

  • Oxford Financial Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Oxford Financial Group sold 23,416 G1 Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $421K.
  • Oxford Financial Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Oxford Financial Group's G1 Therapeutics, Inc. Common Stock position peaked at $568K in Q2 2020.
  • 123 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Oxford Financial Group's 13F filing for Q1 2021, filed 10 May 2021.